Product record

Metformin Hydrochloride Prolonged Release Glimepiride: batches declared Not of Standard Quality

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026

10 batches of products named "Metformin Hydrochloride Prolonged Release Glimepiride" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between January 2023 and June 2026. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.

Records by type

10 records linked to Metformin Hydrochloride Prolonged Release Glimepiride in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
10Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2023 to Jun 2026

View original document

Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

10
NSQ batches
8
Manufacturers
Dissolution
Most common reason
Jun 2026
Latest alert

Flagged batches

Batch Manufacturer Reason declared NSQ Tested by Alert
PRT-250229Mfg 2025-02 · Exp 2027-01 Preet Remedies LtdHimachal Pradesh DescriptionDescription DTL, Bengaluru, KarnatakaState lab Jun 2026
T5107Mfg 2025-07 · Exp 2027-06 Merril Pharma Pvt. LtdGujarat The sample does not conform to IP with respect to the Test of Dissolution for Glimepiride.Dissolution CDL, KolkataCDSCO lab Apr 2026
T5110Mfg 2025-07 · Exp 2027-06 Merril Pharma Pvt. LtdGujarat The sample does not conform to IP with respect to the test of Dissolution of Glimepiride.Dissolution CDL, KolkataCDSCO lab Apr 2026
GVGT1119CMfg 2025-10 · Exp 2027-09 Voizmed Pharma Pvt. LtdHimachal Pradesh The sample does not conform to IP standards with respect to the Dissolution test for Glimepiride IPDissolution Directorate of Food & Drugs, Bambolim, GoaState lab Feb 2026
NHD24148AMfg 2024-03 · Exp 2027-02 Nest Healthcare Pvt.LtdGujarat Sample fails the test Descriptive Part for the tablets as per IP.Other DTL Thiruvananthapuram,KeralaState lab Dec 2025
VPP11224Mfg 2024-12 · Exp 2026-11 Suraksha Pharma Pvt. LtdUttarakhand The sample received does not conform to I.P. 2022 specification with respect to the description only.Description CDTL,HyderabadCDSCO lab Nov 2025
PRT-250235Mfg 2025-02 · Exp 2027-01 Preet Remedies LtdHimachal Pradesh Dissolution test for GlimepirideDissolution RDTL, Bellary, KarnatakaState lab Nov 2025
P9IAV007Mfg 2022-11 · Exp 2024-10 MANKIND PHARMA LTD. Doring BlockSikkim Disintegration and DissolutonDisintegration RDTL GuwahatiState lab Aug 2023
SGT- 0624AMfg 2022-12 · Exp 2024-11 Saitech Medicare Pvt. LtdHimachal Pradesh Assay of GlimepirideAssay RDTL ChandigarhCDSCO lab Jul 2023
GGLV22007Mfg 2022-03 · Exp 2025-02 Eris Lifesciences LimitedAssam DissolutionDissolution RDTL ChandigarhState lab Jan 2023

How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.